Compare Moderna, Inc. (MRNA) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Quantumscape Corp — how do they compare? Moderna, Inc. trades at $60.77 (market cap $24.18B), while Quantumscape Corp trades at $6.39 (market cap $3.90B). The key difference: Moderna, Inc. is far larger — about 6.2× Quantumscape Corp's market cap, and Moderna, Inc. is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals.
| MRNA | QS | |
|---|---|---|
Market Cap | $24.18B | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $18.44 |
52-Week Low | $22.36 | $4.89 |
Enterprise Value | $20.33B | $3.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
